img

Global Morpholine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Morpholine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Morpholine market size was US$ 127.1 million in 2024 and is forecast to a readjusted size of US$ 150.5 million by 2034 with a CAGR of 2.0% during the forecast period 2024-2034.
The United States market for Morpholine is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The China market for Morpholine is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The Europe market for Morpholine is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034..
The global key manufacturers of Morpholine include APL (IN), Anhui Haoyuan (CN), FUYUAN (CN), Liaoyuan (CN), Sinochem (CN), Huntsman (US), Basf (DE), Nippon Nyukazai (JP) and Balaji Amines (IN), etc. In 2024, the global top five players hold a share approximately % in sales volume, and in term of revenue of Morpholine, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Morpholine by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Morpholine market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Morpholine market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


APL (IN)
Anhui Haoyuan (CN)
FUYUAN (CN)
Liaoyuan (CN)
Sinochem (CN)
Huntsman (US)
Basf (DE)
Nippon Nyukazai (JP)
Balaji Amines (IN)
By Type
Ethanolamine method
Two glycol method
By Application
Rubber additives
Corrosion inhibitor
Optical polishing AIDS
Morpholine derivatives
Other
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Morpholine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Morpholine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Morpholine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Morpholine Definition
1.2 Market by Type
1.2.1 Global Morpholine Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Ethanolamine method
1.2.3 Two glycol method
1.3 Market Segment by Application
1.3.1 Global Morpholine Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Rubber additives
1.3.3 Corrosion inhibitor
1.3.4 Optical polishing AIDS
1.3.5 Morpholine derivatives
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Morpholine Sales
2.1 Global Morpholine Revenue Estimates and Forecasts 2018-2034
2.2 Global Morpholine Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Morpholine Revenue by Region
2.3.1 Global Morpholine Revenue by Region (2018-2023)
2.3.2 Global Morpholine Revenue by Region (2024-2034)
2.4 Global Morpholine Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Morpholine Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Morpholine Sales Quantity by Region
2.6.1 Global Morpholine Sales Quantity by Region (2018-2023)
2.6.2 Global Morpholine Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Morpholine Sales Quantity by Manufacturers
3.1.1 Global Morpholine Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Morpholine Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Morpholine Sales in 2024
3.2 Global Morpholine Revenue by Manufacturers
3.2.1 Global Morpholine Revenue by Manufacturers (2018-2023)
3.2.2 Global Morpholine Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Morpholine Revenue in 2024
3.3 Global Morpholine Sales Price by Manufacturers
3.4 Global Key Players of Morpholine, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Morpholine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Morpholine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Morpholine, Product Offered and Application
3.8 Global Key Manufacturers of Morpholine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Morpholine Sales Quantity by Type
4.1.1 Global Morpholine Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Morpholine Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Morpholine Sales Quantity Market Share by Type (2018-2034)
4.2 Global Morpholine Revenue by Type
4.2.1 Global Morpholine Historical Revenue by Type (2018-2023)
4.2.2 Global Morpholine Forecasted Revenue by Type (2024-2034)
4.2.3 Global Morpholine Revenue Market Share by Type (2018-2034)
4.3 Global Morpholine Price by Type
4.3.1 Global Morpholine Price by Type (2018-2023)
4.3.2 Global Morpholine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Morpholine Sales Quantity by Application
5.1.1 Global Morpholine Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Morpholine Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Morpholine Sales Quantity Market Share by Application (2018-2034)
5.2 Global Morpholine Revenue by Application
5.2.1 Global Morpholine Historical Revenue by Application (2018-2023)
5.2.2 Global Morpholine Forecasted Revenue by Application (2024-2034)
5.2.3 Global Morpholine Revenue Market Share by Application (2018-2034)
5.3 Global Morpholine Price by Application
5.3.1 Global Morpholine Price by Application (2018-2023)
5.3.2 Global Morpholine Price Forecast by Application (2024-2034)
6 North America
6.1 North America Morpholine Sales by Company
6.1.1 North America Morpholine Revenue by Company (2018-2023)
6.1.2 North America Morpholine Sales Quantity by Company (2018-2023)
6.2 North America Morpholine Market Size by Type
6.2.1 North America Morpholine Sales Quantity by Type (2018-2034)
6.2.2 North America Morpholine Revenue by Type (2018-2034)
6.3 North America Morpholine Market Size by Application
6.3.1 North America Morpholine Sales Quantity by Application (2018-2034)
6.3.2 North America Morpholine Revenue by Application (2018-2034)
6.4 North America Morpholine Market Size by Country
6.4.1 North America Morpholine Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Morpholine Revenue by Country (2018-2034)
6.4.3 North America Morpholine Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Morpholine Sales by Company
7.1.1 Europe Morpholine Sales Quantity by Company (2018-2023)
7.1.2 Europe Morpholine Revenue by Company (2018-2023)
7.2 Europe Morpholine Market Size by Type
7.2.1 Europe Morpholine Sales Quantity by Type (2018-2034)
7.2.2 Europe Morpholine Revenue by Type (2018-2034)
7.3 Europe Morpholine Market Size by Application
7.3.1 Europe Morpholine Sales Quantity by Application (2018-2034)
7.3.2 Europe Morpholine Revenue by Application (2018-2034)
7.4 Europe Morpholine Market Size by Country
7.4.1 Europe Morpholine Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Morpholine Revenue by Country (2018-2034)
7.4.3 Europe Morpholine Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Morpholine Sales by Company
8.1.1 China Morpholine Sales Quantity by Company (2018-2023)
8.1.2 China Morpholine Revenue by Company (2018-2023)
8.2 China Morpholine Market Size by Type
8.2.1 China Morpholine Sales Quantity by Type (2018-2034)
8.2.2 China Morpholine Revenue by Type (2018-2034)
8.3 China Morpholine Market Size by Application
8.3.1 China Morpholine Sales Quantity by Application (2018-2034)
8.3.2 China Morpholine Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Morpholine Sales by Company
9.1.1 APAC Morpholine Sales Quantity by Company (2018-2023)
9.1.2 APAC Morpholine Revenue by Company (2018-2023)
9.2 APAC Morpholine Market Size by Type
9.2.1 APAC Morpholine Sales Quantity by Type (2018-2034)
9.2.2 APAC Morpholine Revenue by Type (2018-2034)
9.3 APAC Morpholine Market Size by Application
9.3.1 APAC Morpholine Sales Quantity by Application (2018-2034)
9.3.2 APAC Morpholine Revenue by Application (2018-2034)
9.4 APAC Morpholine Market Size by Region
9.4.1 APAC Morpholine Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Morpholine Revenue by Region (2018-2034)
9.4.3 APAC Morpholine Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Morpholine Sales by Company
10.1.1 Middle East, Africa and Latin America Morpholine Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Morpholine Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Morpholine Market Size by Type
10.2.1 Middle East, Africa and Latin America Morpholine Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Morpholine Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Morpholine Market Size by Application
10.3.1 Middle East, Africa and Latin America Morpholine Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Morpholine Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Morpholine Market Size by Country
10.4.1 Middle East, Africa and Latin America Morpholine Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Morpholine Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Morpholine Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 APL (IN)
11.1.1 APL (IN) Company Information
11.1.2 APL (IN) Overview
11.1.3 APL (IN) Morpholine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 APL (IN) Morpholine Products and Services
11.1.5 APL (IN) Morpholine SWOT Analysis
11.1.6 APL (IN) Recent Developments
11.2 Anhui Haoyuan (CN)
11.2.1 Anhui Haoyuan (CN) Company Information
11.2.2 Anhui Haoyuan (CN) Overview
11.2.3 Anhui Haoyuan (CN) Morpholine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Anhui Haoyuan (CN) Morpholine Products and Services
11.2.5 Anhui Haoyuan (CN) Morpholine SWOT Analysis
11.2.6 Anhui Haoyuan (CN) Recent Developments
11.3 FUYUAN (CN)
11.3.1 FUYUAN (CN) Company Information
11.3.2 FUYUAN (CN) Overview
11.3.3 FUYUAN (CN) Morpholine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 FUYUAN (CN) Morpholine Products and Services
11.3.5 FUYUAN (CN) Morpholine SWOT Analysis
11.3.6 FUYUAN (CN) Recent Developments
11.4 Liaoyuan (CN)
11.4.1 Liaoyuan (CN) Company Information
11.4.2 Liaoyuan (CN) Overview
11.4.3 Liaoyuan (CN) Morpholine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Liaoyuan (CN) Morpholine Products and Services
11.4.5 Liaoyuan (CN) Morpholine SWOT Analysis
11.4.6 Liaoyuan (CN) Recent Developments
11.5 Sinochem (CN)
11.5.1 Sinochem (CN) Company Information
11.5.2 Sinochem (CN) Overview
11.5.3 Sinochem (CN) Morpholine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Sinochem (CN) Morpholine Products and Services
11.5.5 Sinochem (CN) Morpholine SWOT Analysis
11.5.6 Sinochem (CN) Recent Developments
11.6 Huntsman (US)
11.6.1 Huntsman (US) Company Information
11.6.2 Huntsman (US) Overview
11.6.3 Huntsman (US) Morpholine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Huntsman (US) Morpholine Products and Services
11.6.5 Huntsman (US) Morpholine SWOT Analysis
11.6.6 Huntsman (US) Recent Developments
11.7 Basf (DE)
11.7.1 Basf (DE) Company Information
11.7.2 Basf (DE) Overview
11.7.3 Basf (DE) Morpholine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Basf (DE) Morpholine Products and Services
11.7.5 Basf (DE) Morpholine SWOT Analysis
11.7.6 Basf (DE) Recent Developments
11.8 Nippon Nyukazai (JP)
11.8.1 Nippon Nyukazai (JP) Company Information
11.8.2 Nippon Nyukazai (JP) Overview
11.8.3 Nippon Nyukazai (JP) Morpholine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Nippon Nyukazai (JP) Morpholine Products and Services
11.8.5 Nippon Nyukazai (JP) Morpholine SWOT Analysis
11.8.6 Nippon Nyukazai (JP) Recent Developments
11.9 Balaji Amines (IN)
11.9.1 Balaji Amines (IN) Company Information
11.9.2 Balaji Amines (IN) Overview
11.9.3 Balaji Amines (IN) Morpholine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Balaji Amines (IN) Morpholine Products and Services
11.9.5 Balaji Amines (IN) Morpholine SWOT Analysis
11.9.6 Balaji Amines (IN) Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Morpholine Value Chain Analysis
12.2 Morpholine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Morpholine Production Mode & Process
12.4 Morpholine Sales and Marketing
12.4.1 Morpholine Sales Channels
12.4.2 Morpholine Distributors
12.5 Morpholine Customers
13 Market Dynamics
13.1 Morpholine Industry Trends
13.2 Morpholine Market Drivers
13.3 Morpholine Market Challenges
13.4 Morpholine Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Morpholine Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Ethanolamine method
Table 3. Major Manufacturers of Two glycol method
Table 4. Global Morpholine Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 5. Global Morpholine Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Morpholine Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Morpholine Revenue Market Share by Region (2018-2023)
Table 8. Global Morpholine Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Morpholine Revenue Market Share by Region (2024-2034)
Table 10. Global Morpholine Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 11. Global Morpholine Sales by Region (2018-2023) & (K Units)
Table 12. Global Morpholine Sales Market Share by Region (2018-2023)
Table 13. Global Morpholine Sales by Region (2024-2034) & (K Units)
Table 14. Global Morpholine Sales Market Share by Region (2024-2034)
Table 15. Global Morpholine Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 16. Global Morpholine Sales Quantity Share by Manufacturers (2018-2023)
Table 17. Global Morpholine Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Morpholine Revenue Share by Manufacturers (2018-2023)
Table 19. Global Morpholine Price by Manufacturers 2018-2023 (USD/Unit)
Table 20. Global Key Players of Morpholine, Industry Ranking, 2021 VS 2024
Table 21. Global Morpholine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Morpholine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Morpholine as of 2024)
Table 23. Global Key Manufacturers of Morpholine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Morpholine, Product Offered and Application
Table 25. Global Key Manufacturers of Morpholine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Morpholine Sales Quantity by Type (2018-2023) & (K Units)
Table 28. Global Morpholine Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Morpholine Sales Quantity Share by Type (2018-2023)
Table 30. Global Morpholine Sales Quantity Share by Type (2024-2034)
Table 31. Global Morpholine Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Morpholine Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Morpholine Revenue Share by Type (2018-2023)
Table 34. Global Morpholine Revenue Share by Type (2024-2034)
Table 35. Morpholine Price by Type (2018-2023) & (USD/Unit)
Table 36. Global Morpholine Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global Morpholine Sales Quantity by Application (2018-2023) & (K Units)
Table 38. Global Morpholine Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Morpholine Sales Quantity Share by Application (2018-2023)
Table 40. Global Morpholine Sales Quantity Share by Application (2024-2034)
Table 41. Global Morpholine Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Morpholine Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Morpholine Revenue Share by Application (2018-2023)
Table 44. Global Morpholine Revenue Share by Application (2024-2034)
Table 45. Morpholine Price by Application (2018-2023) & (USD/Unit)
Table 46. Global Morpholine Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America Morpholine Revenue by Company (2018-2023) & (US$ Million)
Table 48. North America Morpholine Sales Quantity by Company (2018-2023) & (K Units)
Table 49. North America Morpholine Sales Quantity by Type (2018-2023) & (K Units)
Table 50. North America Morpholine Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Morpholine Revenue by Type (2018-2023) & (US$ Million)
Table 52. North America Morpholine Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Morpholine Sales Quantity by Application (2018-2023) & (K Units)
Table 54. North America Morpholine Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Morpholine Revenue by Application (2018-2023) & (US$ Million)
Table 56. North America Morpholine Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Morpholine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 58. North America Morpholine Revenue by Country (2018-2023) & (US$ Million)
Table 59. North America Morpholine Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Morpholine Sales Quantity by Country (2018-2023) & (K Units)
Table 61. North America Morpholine Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Morpholine Sales Quantity by Company (2018-2023) & (K Units)
Table 63. Europe Morpholine Revenue by Company (2018-2023) & (US$ Million)
Table 64. Europe Morpholine Sales Quantity by Type (2018-2023) & (K Units)
Table 65. Europe Morpholine Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Morpholine Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Morpholine Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Morpholine Sales Quantity by Application (2018-2023) & (K Units)
Table 69. Europe Morpholine Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Morpholine Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Morpholine Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Morpholine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 73. Europe Morpholine Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Morpholine Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Morpholine Sales Quantity by Country (2018-2023) & (K Units)
Table 76. Europe Morpholine Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Morpholine Sales Quantity by Company (2018-2023) & (K Units)
Table 78. China Morpholine Revenue by Company (2018-2023) & (US$ Million)
Table 79. China Morpholine Sales Quantity by Type (2018-2023) & (K Units)
Table 80. China Morpholine Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Morpholine Revenue by Type (2018-2023) & (US$ Million)
Table 82. China Morpholine Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Morpholine Sales Quantity by Application (2018-2023) & (K Units)
Table 84. China Morpholine Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Morpholine Revenue by Application (2018-2023) & (US$ Million)
Table 86. China Morpholine Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Morpholine Sales Quantity by Company (2018-2023) & (K Units)
Table 88. APAC Morpholine Revenue by Company (2018-2023) & (US$ Million)
Table 89. APAC Morpholine Sales Quantity by Type (2018-2023) & (K Units)
Table 90. APAC Morpholine Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Morpholine Revenue by Type (2018-2023) & (US$ Million)
Table 92. APAC Morpholine Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Morpholine Sales Quantity by Application (2018-2023) & (K Units)
Table 94. APAC Morpholine Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Morpholine Revenue by Application (2018-2023) & (US$ Million)
Table 96. APAC Morpholine Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Morpholine Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 98. APAC Morpholine Revenue by Region (2018-2023) & (US$ Million)
Table 99. APAC Morpholine Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Morpholine Sales Quantity by Region (2018-2023) & (K Units)
Table 101. APAC Morpholine Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Morpholine Sales Quantity by Company (2018-2023) & (K Units)
Table 103. Middle East, Africa and Latin America Morpholine Revenue by Company (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Morpholine Sales Quantity by Type (2018-2023) & (K Units)
Table 105. Middle East, Africa and Latin America Morpholine Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Morpholine Revenue by Type (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Morpholine Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Morpholine Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Middle East, Africa and Latin America Morpholine Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Morpholine Revenue by Application (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Morpholine Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Morpholine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Morpholine Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Morpholine Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Morpholine Sales Quantity by Country (2018-2023) & (K Units)
Table 116. Middle East, Africa and Latin America Morpholine Sales Quantity by Country (2024-2034) & (K Units)
Table 117. APL (IN) Company Information
Table 118. APL (IN) Description and Overview
Table 119. APL (IN) Morpholine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 120. APL (IN) Morpholine Product and Services
Table 121. APL (IN) Morpholine SWOT Analysis
Table 122. APL (IN) Recent Developments
Table 123. Anhui Haoyuan (CN) Company Information
Table 124. Anhui Haoyuan (CN) Description and Overview
Table 125. Anhui Haoyuan (CN) Morpholine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 126. Anhui Haoyuan (CN) Morpholine Product and Services
Table 127. Anhui Haoyuan (CN) Morpholine SWOT Analysis
Table 128. Anhui Haoyuan (CN) Recent Developments
Table 129. FUYUAN (CN) Company Information
Table 130. FUYUAN (CN) Description and Overview
Table 131. FUYUAN (CN) Morpholine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 132. FUYUAN (CN) Morpholine Product and Services
Table 133. FUYUAN (CN) Morpholine SWOT Analysis
Table 134. FUYUAN (CN) Recent Developments
Table 135. Liaoyuan (CN) Company Information
Table 136. Liaoyuan (CN) Description and Overview
Table 137. Liaoyuan (CN) Morpholine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 138. Liaoyuan (CN) Morpholine Product and Services
Table 139. Liaoyuan (CN) Morpholine SWOT Analysis
Table 140. Liaoyuan (CN) Recent Developments
Table 141. Sinochem (CN) Company Information
Table 142. Sinochem (CN) Description and Overview
Table 143. Sinochem (CN) Morpholine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 144. Sinochem (CN) Morpholine Product and Services
Table 145. Sinochem (CN) Morpholine SWOT Analysis
Table 146. Sinochem (CN) Recent Developments
Table 147. Huntsman (US) Company Information
Table 148. Huntsman (US) Description and Overview
Table 149. Huntsman (US) Morpholine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 150. Huntsman (US) Morpholine Product and Services
Table 151. Huntsman (US) Morpholine SWOT Analysis
Table 152. Huntsman (US) Recent Developments
Table 153. Basf (DE) Company Information
Table 154. Basf (DE) Description and Overview
Table 155. Basf (DE) Morpholine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 156. Basf (DE) Morpholine Product and Services
Table 157. Basf (DE) Morpholine SWOT Analysis
Table 158. Basf (DE) Recent Developments
Table 159. Nippon Nyukazai (JP) Company Information
Table 160. Nippon Nyukazai (JP) Description and Overview
Table 161. Nippon Nyukazai (JP) Morpholine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 162. Nippon Nyukazai (JP) Morpholine Product and Services
Table 163. Nippon Nyukazai (JP) Morpholine SWOT Analysis
Table 164. Nippon Nyukazai (JP) Recent Developments
Table 165. Balaji Amines (IN) Company Information
Table 166. Balaji Amines (IN) Description and Overview
Table 167. Balaji Amines (IN) Morpholine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 168. Balaji Amines (IN) Morpholine Product and Services
Table 169. Balaji Amines (IN) Morpholine SWOT Analysis
Table 170. Balaji Amines (IN) Recent Developments
Table 171. Key Raw Materials Lists
Table 172. Raw Materials Key Suppliers Lists
Table 173. Morpholine Distributors List
Table 174. Morpholine Customers List
Table 175. Morpholine Market Trends
Table 176. Morpholine Market Drivers
Table 177. Morpholine Market Challenges
Table 178. Morpholine Market Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Morpholine Product Picture
Figure 2. Global Morpholine Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Morpholine Market Share by Type in 2024 & 2034
Figure 4. Ethanolamine method Product Picture
Figure 5. Two glycol method Product Picture
Figure 6. Global Morpholine Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 7. Global Morpholine Market Share by Application in 2024 & 2034
Figure 8. Rubber additives
Figure 9. Corrosion inhibitor
Figure 10. Optical polishing AIDS
Figure 11. Morpholine derivatives
Figure 12. Other
Figure 13. Morpholine Report Years Considered
Figure 14. Global Morpholine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Morpholine Revenue 2018-2034 (US$ Million)
Figure 16. Global Morpholine Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 17. Global Morpholine Sales Quantity 2018-2034 (K Units)
Figure 18. Global Morpholine Sales Quantity Market Share by Region (2018-2023)
Figure 19. Global Morpholine Sales Quantity Market Share by Region (2024-2034)
Figure 20. North America Morpholine Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. North America Morpholine Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Morpholine Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. Europe Morpholine Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Morpholine Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. China Morpholine Revenue YoY (2018-2034) & (US$ Million)
Figure 26. APAC Morpholine Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. APAC Morpholine Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Morpholine Sales Quantity YoY (2018-2034) & (K Units)
Figure 29. Middle East, Africa and Latin America Morpholine Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Morpholine Sales Quantity in 2024
Figure 31. The Top 10 and Top 5 Players Market Share by Morpholine Revenue in 2024
Figure 32. Morpholine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 33. Global Morpholine Sales Quantity Market Share by Type (2018-2034)
Figure 34. Global Morpholine Revenue Market Share by Type (2018-2034)
Figure 35. Global Morpholine Sales Quantity Market Share by Application (2018-2034)
Figure 36. Global Morpholine Revenue Market Share by Application (2018-2034)
Figure 37. North America Morpholine Revenue Market Share by Company in 2024
Figure 38. North America Morpholine Sales Quantity Market Share by Company in 2024
Figure 39. North America Morpholine Sales Quantity Market Share by Type (2018-2034)
Figure 40. North America Morpholine Revenue Market Share by Type (2018-2034)
Figure 41. North America Morpholine Sales Quantity Market Share by Application (2018-2034)
Figure 42. North America Morpholine Revenue Market Share by Application (2018-2034)
Figure 43. North America Morpholine Revenue Share by Country (2018-2034)
Figure 44. North America Morpholine Sales Quantity Share by Country (2018-2034)
Figure 45. U.S. Morpholine Revenue (2018-2034) & (US$ Million)
Figure 46. Canada Morpholine Revenue (2018-2034) & (US$ Million)
Figure 47. Europe Morpholine Sales Quantity Market Share by Company in 2024
Figure 48. Europe Morpholine Revenue Market Share by Company in 2024
Figure 49. Europe Morpholine Sales Quantity Market Share by Type (2018-2034)
Figure 50. Europe Morpholine Revenue Market Share by Type (2018-2034)
Figure 51. Europe Morpholine Sales Quantity Market Share by Application (2018-2034)
Figure 52. Europe Morpholine Revenue Market Share by Application (2018-2034)
Figure 53. Europe Morpholine Revenue Share by Country (2018-2034)
Figure 54. Europe Morpholine Sales Quantity Share by Country (2018-2034)
Figure 55. Germany Morpholine Revenue (2018-2034) & (US$ Million)
Figure 56. France Morpholine Revenue (2018-2034) & (US$ Million)
Figure 57. U.K. Morpholine Revenue (2018-2034) & (US$ Million)
Figure 58. Italy Morpholine Revenue (2018-2034) & (US$ Million)
Figure 59. Russia Morpholine Revenue (2018-2034) & (US$ Million)
Figure 60. China Morpholine Sales Quantity Market Share by Company in 2024
Figure 61. China Morpholine Revenue Market Share by Company in 2024
Figure 62. China Morpholine Sales Quantity Market Share by Type (2018-2034)
Figure 63. China Morpholine Revenue Market Share by Type (2018-2034)
Figure 64. China Morpholine Sales Quantity Market Share by Application (2018-2034)
Figure 65. China Morpholine Revenue Market Share by Application (2018-2034)
Figure 66. APAC Morpholine Sales Quantity Market Share by Company in 2024
Figure 67. APAC Morpholine Revenue Market Share by Company in 2024
Figure 68. APAC Morpholine Sales Quantity Market Share by Type (2018-2034)
Figure 69. APAC Morpholine Revenue Market Share by Type (2018-2034)
Figure 70. APAC Morpholine Sales Quantity Market Share by Application (2018-2034)
Figure 71. APAC Morpholine Revenue Market Share by Application (2018-2034)
Figure 72. APAC Morpholine Revenue Share by Region (2018-2034)
Figure 73. APAC Morpholine Sales Quantity Share by Region (2018-2034)
Figure 74. Japan Morpholine Revenue (2018-2034) & (US$ Million)
Figure 75. South Korea Morpholine Revenue (2018-2034) & (US$ Million)
Figure 76. China Taiwan Morpholine Revenue (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Morpholine Revenue (2018-2034) & (US$ Million)
Figure 78. India Morpholine Revenue (2018-2034) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Morpholine Sales Quantity Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Morpholine Revenue Market Share by Company in 2024
Figure 81. Middle East, Africa and Latin America Morpholine Sales Quantity Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Morpholine Revenue Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Morpholine Sales Quantity Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Morpholine Revenue Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Morpholine Sales Quantity Share by Country (2018-2034)
Figure 86. Middle East, Africa and Latin America Morpholine Revenue Share by Country (2018-2034)
Figure 87. Brazil Morpholine Revenue (2018-2034) & (US$ Million)
Figure 88. Mexico Morpholine Revenue (2018-2034) & (US$ Million)
Figure 89. Turkey Morpholine Revenue (2018-2034) & (US$ Million)
Figure 90. Israel Morpholine Revenue (2018-2034) & (US$ Million)
Figure 91. GCC Countries Morpholine Revenue (2018-2034) & (US$ Million)
Figure 92. Morpholine Value Chain
Figure 93. Morpholine Production Process
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed